These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19855436)

  • 21. Differential sulfation remodelling of heparan sulfate by extracellular 6-O-sulfatases regulates fibroblast growth factor-induced boundary formation by glial cells: implications for glial cell transplantation.
    Higginson JR; Thompson SM; Santos-Silva A; Guimond SE; Turnbull JE; Barnett SC
    J Neurosci; 2012 Nov; 32(45):15902-12. PubMed ID: 23136428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation.
    Ai X; Kitazawa T; Do AT; Kusche-Gullberg M; Labosky PA; Emerson CP
    Development; 2007 Sep; 134(18):3327-38. PubMed ID: 17720696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced tumorigenic potential of colorectal cancer cells by extracellular sulfatases.
    Vicente CM; Lima MA; Yates EA; Nader HB; Toma L
    Mol Cancer Res; 2015 Mar; 13(3):510-23. PubMed ID: 25477293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression regulation and function of heparan sulfate 6-O-endosulfatases in the spermatogonial stem cell niche.
    Langsdorf A; Schumacher V; Shi X; Tran T; Zaia J; Jain S; Taglienti M; Kreidberg JA; Fine A; Ai X
    Glycobiology; 2011 Feb; 21(2):152-61. PubMed ID: 20855470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in mice.
    Nagamine S; Tamba M; Ishimine H; Araki K; Shiomi K; Okada T; Ohto T; Kunita S; Takahashi S; Wismans RG; van Kuppevelt TH; Masu M; Keino-Masu K
    J Biol Chem; 2012 Mar; 287(12):9579-90. PubMed ID: 22298771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trisaccharide Sulfate and Its Sulfonamide as an Effective Substrate and Inhibitor of Human Endo-
    Chiu LT; Sabbavarapu NM; Lin WC; Fan CY; Wu CC; Cheng TR; Wong CH; Hung SC
    J Am Chem Soc; 2020 Mar; 142(11):5282-5292. PubMed ID: 32083852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a phage display antibody to measure the enzymatic activity of the Sulfs.
    Uchimura K; Lemjabbar-Alaoui H; van Kuppevelt TH; Rosen SD
    Methods Enzymol; 2010; 480():51-64. PubMed ID: 20816204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer.
    Huo W; Zhu XM; Pan XY; Du M; Sun Z; Li ZM
    Math Biosci Eng; 2019 May; 16(5):4607-4621. PubMed ID: 31499680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycomics analysis of mammalian heparan sulfates modified by the human extracellular sulfatase HSulf2.
    Staples GO; Shi X; Zaia J
    PLoS One; 2011 Feb; 6(2):e16689. PubMed ID: 21347431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human extracellular sulfatases use a dual mechanism for regulation of growth factor interactions with heparan sulfate proteoglycans.
    Timm BM; Follmar JL; Porell RN; Glass K; Thacker BE; Glass CA; Godula K
    bioRxiv; 2023 Nov; ():. PubMed ID: 38045270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparan Sulfate-Editing Extracellular Sulfatases Enhance VEGF Bioavailability for Ischemic Heart Repair.
    Korf-Klingebiel M; Reboll MR; Grote K; Schleiner H; Wang Y; Wu X; Klede S; Mikhed Y; Bauersachs J; Klintschar M; Rudat C; Kispert A; Niessen HW; Lübke T; Dierks T; Wollert KC
    Circ Res; 2019 Oct; 125(9):787-801. PubMed ID: 31434553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways.
    Otsuki S; Hanson SR; Miyaki S; Grogan SP; Kinoshita M; Asahara H; Wong CH; Lotz MK
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10202-7. PubMed ID: 20479257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilage.
    Otsuki S; Taniguchi N; Grogan SP; D'Lima D; Kinoshita M; Lotz M
    Arthritis Res Ther; 2008; 10(3):R61. PubMed ID: 18507859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HS and Inflammation: A Potential Playground for the Sulfs?
    El Masri R; Crétinon Y; Gout E; Vivès RR
    Front Immunol; 2020; 11():570. PubMed ID: 32318065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts.
    Peterson SM; Iskenderian A; Cook L; Romashko A; Tobin K; Jones M; Norton A; Gómez-Yafal A; Heartlein MW; Concino MF; Liaw L; Martini PG
    BMC Cancer; 2010 Aug; 10():427. PubMed ID: 20707913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HpSulf, a heparan sulfate 6-O-endosulfatase, is involved in the regulation of VEGF signaling during sea urchin development.
    Fujita K; Takechi E; Sakamoto N; Sumiyoshi N; Izumi S; Miyamoto T; Matsuura S; Tsurugaya T; Akasaka K; Yamamoto T
    Mech Dev; 2010 Apr; 127(3-4):235-45. PubMed ID: 20036737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells.
    Zhang H; Newman DR; Sannes PL
    Respir Res; 2012 Aug; 13(1):69. PubMed ID: 22873647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survival.
    Yang JD; Sun Z; Hu C; Lai J; Dove R; Nakamura I; Lee JS; Thorgeirsson SS; Kang KJ; Chu IS; Roberts LR
    Genes Chromosomes Cancer; 2011 Feb; 50(2):122-35. PubMed ID: 21104785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SULFs in human neoplasia: implication as progression and prognosis factors.
    Bret C; Moreaux J; Schved JF; Hose D; Klein B
    J Transl Med; 2011 May; 9():72. PubMed ID: 21599997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.